Adaptive Biotechnologies president reports stock sale

Adaptive Biotechnologies President Julie Rubinstein disclosed the sale of 35,643 shares at $26.60 in a Form 4 filing. The filing also shows an exercise of 35,643 shares at $12.14 under a 10b5-1 plan.